Company formed for new method of precocious mastopathy diagnosis. Targeting mass test for “ Mastopathy Screening Diagnostics”. The results are immediate having ingested a Fe59 pill . The method was presented in exhibitions and symposia. Intended for testing women, in the cancer risk group with the purpose of pre-existing disease finding. Detecting benign and malignant tumors, dis hormonal and inflammatory mastopathies. No touching or nudity.